Clin2
NCT04775355Possibly a fitRecruiting

Track urine and gut changes during prostate cancer treatment

Stage I Prostate Cancer AJCC v7Stage II Prostate Cancer AJCC v7Stage IIA Prostate Cancer AJCC v7Stage IIB Prostate Cancer AJCC v7Stage III Prostate Cancer AJCC v7Stage IV Prostate Cancer AJCC v7

Part of Cancer, Kidney & urinary clinical trials.

This study looks at how your urine and gut (intestine) microbes change while you undergo prostate cancer treatments, including hormone therapy (androgen deprivation) and/or radiation. The goal is to better understand these biological changes, which may help improve future treatment planning.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have prostate cancer confirmed by a medical test (pathology), and you have a radiation plan
  • You must be 18 years old or older
  • You must be willing to collect urine and stool samples at the study’s scheduled times
  • You’re planning either: radiation with hormone therapy, or radiation without hormone therapy (study groups differ by plan)
  • You do not have inflammatory bowel disease or a history of bladder inflammation (cystitis)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06067269Recruiting· Phase 2
Hormone therapy and precise radiation for intermediate-risk prostate cancer

This trial tests whether giving a short course of hormone therapy (apalutamide) along with targeted, high-dose radiation (SBRT) is safe and effective for men with a specific type of intermediate-risk prostate cancer. You may benefit if you fit the exact risk and test criteria.

Los Angeles, California
NCT02997709Recruiting
Collecting prostate cancer body marker samples during treatment

This study collects and measures “biomarkers” (measurable signs in the body) from people with prostate cancer who are about to have surgery or radiation. The goal is to understand how prostate cancer behaves during treatment, which may help improve care in the future.

Miami, Florida
NCT03237026Recruiting
Urine tests to predict outcomes in prostate cancer treatment

This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).

Taipei
NCT06423976Recruiting
Studying microbes in prostate cancer tumors

This trial collects tumor samples from men with prostate cancer to study the bacteria and other microbes inside the tumor. It aims to learn how these microbes might affect the cancer and treatment.

Sutton, Surrey
NCT06116851Recruiting
Prostate health, gut bacteria, and cancer risk

This study looks at how your gut bacteria and prostate health may be connected to cancer risk. It may help find new ways to predict or prevent prostate cancer.

Turku
NCT06640959Recruiting
Bowel health study for prostate cancer radiation

This study tests whether a daily drink can help reduce bowel side effects caused by radiation for prostate cancer. If you are about to start radiation for intermediate to high-risk prostate cancer, you may be able to join.

Manchester, Greater Manchester

Hear when a new Stage IV Prostate Cancer AJCC v7 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.